James Rickard

2.4k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

James Rickard is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, James Rickard has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in James Rickard's work include Cell death mechanisms and regulation (6 papers), interferon and immune responses (4 papers) and NF-κB Signaling Pathways (4 papers). James Rickard is often cited by papers focused on Cell death mechanisms and regulation (6 papers), interferon and immune responses (4 papers) and NF-κB Signaling Pathways (4 papers). James Rickard collaborates with scholars based in Australia, United Kingdom and Switzerland. James Rickard's co-authors include John Silke, Motti Gerlic, Holly Anderton, W. Wei‐Lynn Wong, Ueli Nachbur, Henning Walczak, Christoph H. Emmerich, Eva Rieser, Björn Gerlach and Uwe Warnken and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Immunology.

In The Last Decade

James Rickard

11 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linear ubiquitination prevents inflammation and regulates immune signalling

2011 725 citations Björn Gerlach, Stefanie M. Cordier et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Rickard Australia	7	1.1k	703	411	260	197	14	1.4k
Nufail Khan Australia	8	1.3k 1.2×	766 1.1×	392 1.0×	269 1.0×	209 1.1×	11	1.6k
Tatiana Goncharov France	14	1.3k 1.2×	720 1.0×	533 1.3×	347 1.3×	186 0.9×	24	1.6k
Diep Chau Australia	11	1.5k 1.3×	840 1.2×	548 1.3×	359 1.4×	216 1.1×	14	1.8k
Alexander Golks Germany	12	1.0k 0.9×	534 0.8×	217 0.5×	263 1.0×	156 0.8×	12	1.3k
Alicia Algeciras-Schimnich United States	15	836 0.7×	564 0.8×	223 0.5×	195 0.8×	178 0.9×	21	1.3k
Mike Hupe Germany	10	1.0k 0.9×	562 0.8×	247 0.6×	171 0.7×	171 0.9×	10	1.3k
Guanhua Song China	19	829 0.7×	516 0.7×	386 0.9×	284 1.1×	139 0.7×	43	1.4k
Nicole Hermance United States	14	1.2k 1.1×	576 0.8×	284 0.7×	283 1.1×	126 0.6×	19	1.6k
Xuefeng Wu United States	25	1.2k 1.1×	953 1.4×	684 1.7×	445 1.7×	268 1.4×	42	2.0k
Élodie Lafont France	13	831 0.7×	452 0.6×	273 0.7×	210 0.8×	155 0.8×	19	1.1k

Countries citing papers authored by James Rickard

Since Specialization

Citations

This map shows the geographic impact of James Rickard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rickard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rickard more than expected).

Fields of papers citing papers by James Rickard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Rickard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rickard. The network helps show where James Rickard may publish in the future.

Co-authorship network of co-authors of James Rickard

This figure shows the co-authorship network connecting the top 25 collaborators of James Rickard. A scholar is included among the top collaborators of James Rickard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Rickard. James Rickard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Ma, Xiuquan, James Rickard, Catherine N. Hall, et al.. (2025). NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors. Science Advances. 11(28). eadv0079–eadv0079.

2.

Celentano, Antonio, James Rickard, Natasha Silke, et al.. (2025). Enabling high-resolution diagnostic oral confocal laser endomicroscopy in mice. Methods. 239. 169–181.

3.

Chan, K. L. Andrew, et al.. (2024). Manufacture and Initial Characterisation of RAPIDTM Biodynamic Haematogel, an Autologous Platelet and Leukocyte-Rich Plasma Gel for Diabetic Foot Ulcers. Gels. 10(9). 572–572. 1 indexed citations

4.

Jain, Reema, Julie M. Sheridan, Melanie Heinlein, et al.. (2021). Dual roles for LUBAC signaling in thymic epithelial cell development and survival. Cell Death and Differentiation. 28(10). 2946–2956. 6 indexed citations

5.

Anderton, Holly, Esther Bandala‐Sanchez, Daniel S. Simpson, et al.. (2018). RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development. Cell Death and Differentiation. 26(5). 877–889. 55 indexed citations

6.

Tanzer, Maria C., Nufail Khan, James Rickard, et al.. (2017). Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death and Differentiation. 24(3). 481–491. 38 indexed citations

7.

Anderton, Holly, James Rickard, George A. Varigos, Najoua Lalaoui, & John Silke. (2017). Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation. Journal of Investigative Dermatology. 137(11). 2371–2379. 28 indexed citations

8.

Silke, John, James Rickard, & Motti Gerlic. (2015). The diverse role of RIP kinases in necroptosis and inflammation. Nature Immunology. 16(7). 689–697. 409 indexed citations

9.

Etemadi, Nima, Michaël Chopin, Holly Anderton, et al.. (2015). TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. eLife. 4. 88 indexed citations

10.

Tanzer, Maria C., Nufail Khan, James Rickard, Nima Etemadi, & John Silke. (2014). 179. Cytokine. 70(1). 71–71.

11.

Grills, Brian L., et al.. (2014). Sharpin is a key regulator of skeletal homeostasis in a TNF-dependent manner. PubMed. 14(4). 454–63. 4 indexed citations

12.

Etemadi, Nima, James Rickard, Holly Anderton, et al.. (2014). 47. Cytokine. 70(1). 39–39. 1 indexed citations

13.

Gentle, Ian E., W. Wei‐Lynn Wong, Wendy D. Cook, et al.. (2011). In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8. Journal of Biological Chemistry. 286(15). 13282–13291. 81 indexed citations

14.

Gerlach, Björn, Stefanie M. Cordier, Christoph H. Emmerich, et al.. (2011). Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 471(7340). 591–596. 725 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact